153 related articles for article (PubMed ID: 37541863)
21. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas.
Ikeguchi R; Shimizu Y; Abe K; Shimizu S; Maruyama T; Nitta M; Abe K; Kawamata T; Kitagawa K
Mult Scler Relat Disord; 2018 Nov; 26():77-84. PubMed ID: 30237108
[TBL] [Abstract][Full Text] [Related]
22. Tumefactive Demyelinating Lesion Differentiated from a Brain Tumor Using a Combination of Magnetic Resonance Imaging and (11)C-methionine Positron Emission Tomography.
Ninomiya S; Hara M; Morita A; Teramoto H; Momose M; Takahashi T; Kamei S
Intern Med; 2015; 54(11):1411-4. PubMed ID: 26027998
[TBL] [Abstract][Full Text] [Related]
23. Tumefactive multiple sclerosis masquerade as a central nervous system tumor: a case report.
Turkistani AN; Alshamrani FJ; Shareefi GF; Alsulaiman A
Electron Physician; 2018 Aug; 10(8):7180-7184. PubMed ID: 30214700
[TBL] [Abstract][Full Text] [Related]
24. Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Totaro R; Di Carmine C; Splendiani A; Torlone S; Patriarca L; Carrocci C; Sciamanna S; Marini C; Carolei A
Neurol Sci; 2016 Jul; 37(7):1113-7. PubMed ID: 27083895
[TBL] [Abstract][Full Text] [Related]
25. Tumefactive Demyelinating Lesions and Pregnancy.
Plantone D; Piantadosi C; Ruggieri S; Anelli V; Koudriavtseva T
Neurol India; 2019; 67(6):1519-1521. PubMed ID: 31857550
[TBL] [Abstract][Full Text] [Related]
26. Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.
Kobayashi M; Shimizu Y; Shibata N; Uchiyama S
J Neurol; 2014 Oct; 261(10):1902-10. PubMed ID: 25034274
[TBL] [Abstract][Full Text] [Related]
27. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand.
Ongphichetmetha T; Aungsumart S; Siritho S; Apiwattanakul M; Tanboon J; Rattanathamsakul N; Prayoonwiwat N; Jitprapaikulsan J
Sci Rep; 2024 Jan; 14(1):1426. PubMed ID: 38228919
[TBL] [Abstract][Full Text] [Related]
28. Tumefactive demyelinating lesions (TDLs): A case series of clinicoradiological features.
Jain RS; Khan I; Kandelwal K; Desai T
Clin Neurol Neurosurg; 2017 Nov; 162():91-94. PubMed ID: 28987645
[TBL] [Abstract][Full Text] [Related]
29. Tumefactive demyelinating lesions.
Dagher AP; Smirniotopoulos J
Neuroradiology; 1996 Aug; 38(6):560-5. PubMed ID: 8880719
[TBL] [Abstract][Full Text] [Related]
30. Pitfalls in the diagnosis of a tumefactive demyelinating lesion: A case report.
Gavra M; Boviatsis E; Stavrinou LC; Sakas D
J Med Case Rep; 2011 Jun; 5():217. PubMed ID: 21649896
[TBL] [Abstract][Full Text] [Related]
31. [A case of pediatric multiple sclerosis presenting with a tumefactive demyelinating lesion].
Majima H; Ito T; Koyama N
Rinsho Shinkeigaku; 2017 Feb; 57(2):88-91. PubMed ID: 28132974
[TBL] [Abstract][Full Text] [Related]
32. Phenotyping variants of tumefactive demyelinating lesions according to clinical and radiological features-A case series.
Boyle T; Fernando SL; Drummond J; Fontes A; Parratt J
Front Neurol; 2023; 14():1092373. PubMed ID: 36816572
[TBL] [Abstract][Full Text] [Related]
33. Progression of tumefactive demyelinating lesion in a child demonstrated with MRI.
De Simone M; Brogna B; Spitaleri DL; Cicarelli G; Fantozzi R; Guida B
Radiol Case Rep; 2018 Feb; 13(1):254-260. PubMed ID: 29487664
[TBL] [Abstract][Full Text] [Related]
34. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
[TBL] [Abstract][Full Text] [Related]
35. Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging.
Enzinger C; Strasser-Fuchs S; Ropele S; Kapeller P; Kleinert R; Fazekas F
Mult Scler; 2005 Apr; 11(2):135-9. PubMed ID: 15794384
[TBL] [Abstract][Full Text] [Related]
36. Relapsing Tumefactive Demyelination: A Case Report.
Omerhodžić I; Džurlić A; Lisica D; Mahmutbegović N; Nikšić M; Bilalović N; Suljić E
Acta Med Acad; 2018 Nov; 47(2):193-198. PubMed ID: 30585071
[TBL] [Abstract][Full Text] [Related]
37. MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1643-1649. PubMed ID: 30115676
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of HIV-associated tumefactive demyelinating lesions with corticosteroids and cyclophosphamide: a case report.
Lazzarin SM; Cannizzaro M; Russo T; Sangalli F; Callea M; Colombo B; Moiola L; Filippi M
J Neurol; 2020 Dec; 267(12):3773-3775. PubMed ID: 33141250
[No Abstract] [Full Text] [Related]
39. Solitary tumefactive demyelinating lesions in children.
Morin MP; Patenaude Y; Sinsky AB; Banwell B; Sébire G
J Child Neurol; 2011 Aug; 26(8):995-9. PubMed ID: 21555780
[TBL] [Abstract][Full Text] [Related]
40. Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.
Barbosa BC; Marchiori E; Leal Leidersnaider C; Brandao L; Castillo M
Neuroradiol J; 2019 Apr; 32(2):103-107. PubMed ID: 30667319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
